首页>
外国专利>
Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
展开▼
机译:减少镰状红细胞脱水并延迟原位红细胞镰状发生的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a chemical class of active compounds to be used as efficacious drugs in the treatment of sickle cell disease. The active compounds include imidazole derivatives, nitroimidazole derivatives, and triazole derivatives. These compounds are to be administered by any preferred route of administration including oral, intramuscular, intravenous, and any other parenteral route. If desired, these drugs may also be administered transmucosally, or subcutaneously, or using a dermal patch on the skin. In addition, the methodology is effective for both long term and short term therapy; may be employed prophylactically and/or therapeutically; and may be used in emergency, acute crisis clinical situations.
展开▼